CASSANELLO, GIULIO
CASSANELLO, GIULIO
Universita' degli Studi di MILANO
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features
2023 B. Fattizzo, F. Serpenti, F. Versino, G. Cassanello, L.M. Cro, M. Barbieri, G.A. Croci, N. Revelli, M.G. Della Porta, W. Barcellini
Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review
2023 B. Fattizzo, R. Pasquale, G.A. Croci, L. Pettine, G. Cassanello, W. Barcellini
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023 G. Cassanello, F. Serpenti, F. Bagnoli, G. Saporiti, M. Goldaniga, F. Cavallaro, K. Barbullushi, V. Bellani, G. Galassi, F. Onida
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
2022 B. Fattizzo, G.V. Levati, J.A. Giannotta, G. Cassanello, L.M. Cro, A. Zaninoni, M. Barbieri, G.A. Croci, N. Revelli, W. Barcellini
SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma
2020 C. Rusconi, G. Cassanello, A. Guidetti, C. Oltolini, V. Marasco, L. Morabito, M. Della Porta, R. Lanocita, G. Papagni, C. Carniti, P. Corradini